We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Dengue Shock Protein Shows Potential as Vaccine

News   Sep 10, 2015

 
Dengue Shock Protein Shows Potential as Vaccine
 
 
Advertisement
 

RELATED ARTICLES

Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine

News

The Danish Health Authority has decided to continue its vaccination programme against COVID-19 without the vaccine from AstraZeneca.

READ MORE

The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine

News

The United States Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) have recommended pausing the use of the Johnson & Johnson (Janssen) COVID-19 vaccine. In addition, Janssen has declared that it will "proactively delay" the rollout of the vaccine in Europe.

READ MORE

Blood Test Detects Marker of Metastatic Cancers, Infection and Neurological Disease

News

Scientists at the Walter Reed Army Institute of Research demonstrated the potential of a novel blood test for cathepsin B, a well-studied protein important to brain development and function, as an indicator for a range of disease states.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE